Sanara MedTech Inc. SMTI Allowance for Doubtful Accounts
Allowance for Doubtful Accounts at other companies
Other financials
Where this comes from
Reported directly by Sanara MedTech Inc. in its filing.
Tagged under the XBRL concept us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables.
The official record: Sanara MedTech Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sanara MedTech Inc.'s allowance for doubtful accounts.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sanara MedTech Inc.'s allowance for doubtful accounts?
- Sanara MedTech Inc. (SMTI) reported allowance for doubtful accounts of $6.69K in Q1 2026.
- How has Sanara MedTech Inc.'s allowance for doubtful accounts changed year-over-year?
- Sanara MedTech Inc.'s allowance for doubtful accounts increased by 14.8% year-over-year, from $5.83K to $6.69K.
- What is the long-term trend for Sanara MedTech Inc.'s allowance for doubtful accounts?
- Over 5 years (2020 to 2025), Sanara MedTech Inc.'s allowance for doubtful accounts has grown at a -100.0% compound annual growth rate (CAGR), from $64.99K to $0.
- What does allowance for doubtful accounts mean?
- This is a contra-asset account representing the estimated portion of accounts receivable that the company expects will not be collected from customers. It reflects management's assessment of credit risk and the quality of the company's sales ledger. An increasing trend may signal deteriorating customer creditworthiness or challenges in the collection process.